NO982816L - 17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav - Google Patents

17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav

Info

Publication number
NO982816L
NO982816L NO982816A NO982816A NO982816L NO 982816 L NO982816 L NO 982816L NO 982816 A NO982816 A NO 982816A NO 982816 A NO982816 A NO 982816A NO 982816 L NO982816 L NO 982816L
Authority
NO
Norway
Prior art keywords
derivatives
oxo
enrichment
vitamin
preparation
Prior art date
Application number
NO982816A
Other languages
English (en)
Norwegian (no)
Other versions
NO982816D0 (no
Inventor
Robert Henry Hesse
Maurice Murdoch Pechet
Sundara Katugam Srinivas Setty
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Publication of NO982816D0 publication Critical patent/NO982816D0/no
Publication of NO982816L publication Critical patent/NO982816L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO982816A 1995-12-21 1998-06-18 17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav NO982816L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526208.5A GB9526208D0 (en) 1995-12-21 1995-12-21 Chemical compounds
PCT/GB1996/003218 WO1997023453A1 (en) 1995-12-21 1996-12-23 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
NO982816D0 NO982816D0 (no) 1998-06-18
NO982816L true NO982816L (no) 1998-08-21

Family

ID=10785847

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982816A NO982816L (no) 1995-12-21 1998-06-18 17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav

Country Status (21)

Country Link
US (2) US6372926B2 (cs)
EP (1) EP0874815B1 (cs)
JP (1) JP2000503636A (cs)
KR (1) KR19990076664A (cs)
CN (1) CN1086694C (cs)
AT (1) ATE200663T1 (cs)
AU (1) AU710680B2 (cs)
CA (1) CA2241011A1 (cs)
CZ (1) CZ290930B6 (cs)
DE (1) DE69612568T2 (cs)
DK (1) DK0874815T3 (cs)
ES (1) ES2155948T3 (cs)
GB (1) GB9526208D0 (cs)
GR (1) GR3036132T3 (cs)
HU (1) HUP9903786A3 (cs)
IL (1) IL125027A0 (cs)
NO (1) NO982816L (cs)
NZ (1) NZ324775A (cs)
PT (1) PT874815E (cs)
WO (1) WO1997023453A1 (cs)
ZA (1) ZA9610874B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003262179A1 (en) * 2002-04-11 2003-10-27 Instytut Farmaceutyczny Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds
US7253293B2 (en) * 2004-01-06 2007-08-07 Andrzej Slominski Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
WO2006100285A1 (en) * 2005-03-23 2006-09-28 Bioxell Spa Use of vitamin d compounds to treat endometriosis
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs
EP2393494A1 (en) * 2009-01-27 2011-12-14 Berg Biosystems, LLC Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
KR101791828B1 (ko) 2009-08-14 2017-10-31 베르그 엘엘씨 탈모증 치료용 비타민 d3 및 이의 유사체들
JP5563324B2 (ja) * 2010-02-03 2014-07-30 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトール中間体およびその製造方法
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034543B2 (ja) * 1977-07-01 1985-08-09 中外製薬株式会社 ビタミンd誘導体
GB9214202D0 (en) 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
GB9220439D0 (en) * 1992-09-28 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
US5397776A (en) * 1993-08-20 1995-03-14 Wisconsin Alumni Research Foundation Vitamin D compounds with anti-progesterone activity

Also Published As

Publication number Publication date
GR3036132T3 (en) 2001-09-28
GB9526208D0 (en) 1996-02-21
HUP9903786A2 (hu) 2000-03-28
KR19990076664A (ko) 1999-10-15
IL125027A0 (en) 1999-01-26
JP2000503636A (ja) 2000-03-28
WO1997023453A1 (en) 1997-07-03
US6372926B2 (en) 2002-04-16
HUP9903786A3 (en) 2000-09-28
NZ324775A (en) 1999-02-25
NO982816D0 (no) 1998-06-18
DE69612568D1 (de) 2001-05-23
ES2155948T3 (es) 2001-06-01
EP0874815A1 (en) 1998-11-04
CN1209120A (zh) 1999-02-24
AU710680B2 (en) 1999-09-30
CZ290930B6 (cs) 2002-11-13
DK0874815T3 (da) 2002-03-04
AU1202597A (en) 1997-07-17
US20020010163A1 (en) 2002-01-24
EP0874815B1 (en) 2001-04-18
CN1086694C (zh) 2002-06-26
DE69612568T2 (de) 2001-09-06
PT874815E (pt) 2001-07-31
CA2241011A1 (en) 1997-07-03
CZ194798A3 (cs) 1998-11-11
ATE200663T1 (de) 2001-05-15
ZA9610874B (en) 1997-06-18
US20020188142A1 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
LV12618A (en) Use of sulphamate derivatives as steroid sulphatase inhibitors
NZ331941A (en) Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis
AU1497997A (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
CA2223513A1 (en) Betulinic acid derivatives and uses therefor
NO982816L (no) 17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav
FR2741619A1 (fr) Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
KR910015590A (ko) 11베타 위치에 아미드 또는 카르바메이트 관능기 함유 탄화 수소 사슬을 가지는 신규한 19-노르 스테로이드, 그의 제조방법 및 중간체, 약물 용도 및 이들을 함유하는 제약 조성물
FI91070B (fi) Parannus androsta-1,4-dieeni-3,17-dionin 6-metyleenijohdannaisten synteesissä
DE69518410D1 (de) 22-thiavitamin-d3-derivate
NO982229L (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som anti-inflammatoriske midler
DE69939106D1 (de) Verfahren zur Herstellung von ED-71
EP0605728A4 (en) Chromone derivative and aldose reductase inhibitor containing the same as active ingredient.
ES2150151T3 (es) Derivados de 21-(2-oxo-tetrahidrofuran)-tio-pregnano, un procedimiento para su produccion y composiciones farmaceuticas que los contienen.
HU9400795D0 (en) Benzene derivatives and pharmaceutical compositions containing them as active components
MX9604735A (es) Derivados de la 22-tiavitamina d3.
EE200200302A (et) Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid
ES2179550T3 (es) 15-metil-ciclopropanoesteroides y proceso para su preparacion.
NO20014530L (no) Fremgangsmåte for fremstilling av 4, 4-dimetyl-3<beta>- hydroksy-pregna-8, 14-dien-21-karboksylsyreestere ogmellomprodukter ved fremgangsmåten
ECSP961710A (es) Nuevos derivados de la etanolamina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application